Insider Trading activities at Vericel Corp (VCEL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vericel Corp (VCEL) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vericel Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 887359.

Total stock buying since 2016: $10,279.
Total stock sales since 2016: $55,384,368.
Total stock option exercises since 2016: $10,698,887.


 1   2 
16 insiders reported insider trading activities at Vericel Corp (VCEL):
Insider trading activities of Flynn Sean C.
Insider trading activities of Zerbe Robert L Md
Insider trading activities of Wright Lisa
Insider trading activities of Rubino Alan L
Insider trading activities of Mclaughlin Kevin F
Insider trading activities of Halpin Michael
Insider trading activities of Mara Joseph Anthony Jr
Insider trading activities of Blutt Mitchell J Md
Insider trading activities of Wotton Paul K
Insider trading activities of Gilman Steven C
Insider trading activities of Hagen Heidi
Insider trading activities of Orlando Daniel
Insider trading activities of Siegal Jonathan
Insider trading activities of Michel Gerard J
Insider trading activities of Colangelo Dominick
Insider trading activities of Hopper Jonathan Mark

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Vericel Corp (VCEL).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 179,024 $8,114,527 218,583 $1,115,904
2024 0 $0 481,462 $22,617,175 600,131 $2,649,285
2023 0 $0 121,650 $3,966,665 193,540 $1,447,145
2022 0 $0 17,969 $729,798 73,369 $289,500
2021 0 $0 193,805 $9,865,968 215,444 $1,679,957
2020 0 $0 90,488 $2,124,097 270,937 $1,154,863
2019 0 $0 197,008 $3,314,368 364,316 $1,001,181
2018 890 $10,279 281,194 $4,004,970 462,429 $1,361,052
2016 0 $0 120,000 $646,800 0 $0

Table 2. Monthly summary of insider trading at Vericel Corp (VCEL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 10,000 $357,700 10,000 $180,000
2025-08 0 $0 7,000 $251,440 7,000 $19,320
2025-05 0 $0 7,000 $279,860 7,000 $19,320
2025-04 0 $0 49,700 $2,062,549 68,900 $136,674
2025-03 0 $0 91,183 $4,330,850 82,183 $483,966
2025-02 0 $0 10,233 $589,872 39,592 $85,914
2025-01 0 $0 3,908 $242,256 3,908 $190,710
2024-12 0 $0 12,600 $739,872 10,000 $166,600
2024-11 0 $0 42,000 $2,305,030 42,000 $131,880
2024-10 0 $0 47,234 $1,930,512 56,666 $295,340
2024-09 0 $0 55,834 $2,534,105 56,771 $310,033
2024-08 0 $0 42,000 $1,921,360 42,000 $131,880
2024-07 0 $0 55,545 $2,858,850 50,000 $349,450
2024-06 0 $0 50,000 $2,202,993 50,000 $349,449
2024-05 0 $0 10,000 $499,900 32,400 $109,500
2024-04 0 $0 105,000 $4,780,650 130,445 $672,134
2024-03 0 $0 13,027 $610,428 3,278 $12,259
2024-02 0 $0 35,722 $1,713,307 123,571 $108,400
2024-01 0 $0 12,500 $520,168 3,000 $12,360
2023-12 0 $0 54,935 $1,926,200 48,397 $172,777
2023-11 0 $0 22,447 $799,798 22,447 $180,368
2023-10 0 $0 0 $0 938 $0
2023-07 0 $0 1,000 $38,840 0 $0
2023-06 0 $0 3,000 $108,000 433 $0

Table 3. Detailed insider trading at Vericel Corp (VCEL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Hopper Jonathan Mark (Chief Medical Officer) Sale 10,000 35.77 357,700
2025-09-02 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 10,000 18.00 180,000
2025-08-06 Mclaughlin Kevin F Sale 7,000 35.92 251,440
2025-08-06 Mclaughlin Kevin F Option Ex 7,000 2.76 19,320
2025-05-07 Mclaughlin Kevin F Sale 7,000 39.98 279,860
2025-05-07 Mclaughlin Kevin F Option Ex 7,000 2.76 19,320
2025-04-30 Wright Lisa Option Ex 3,200 .00 0
2025-04-30 Hagen Heidi Option Ex 3,200 .00 0
2025-04-30 Rubino Alan L Option Ex 3,200 .00 0
2025-04-30 Wotton Paul K Option Ex 3,200 .00 0
2025-04-30 Zerbe Robert L Md Option Ex 3,200 .00 0
2025-04-30 Mclaughlin Kevin F Option Ex 3,200 .00 0
2025-04-10 Colangelo Dominick (President and CEO) Sale 24,850 41.89 1,040,966
2025-04-10 Colangelo Dominick (President and CEO) Option Ex 24,850 2.75 68,337
2025-04-09 Colangelo Dominick (President and CEO) Sale 24,850 41.11 1,021,583
2025-04-09 Colangelo Dominick (President and CEO) Option Ex 24,850 2.75 68,337
2025-03-13 Colangelo Dominick (President and CEO) Sale 26,592 45.78 1,217,381
2025-03-13 Colangelo Dominick (President and CEO) Option Ex 26,592 1.95 51,854
2025-03-12 Colangelo Dominick (President and CEO) Sale 26,591 46.31 1,231,429
2025-03-12 Colangelo Dominick (President and CEO) Option Ex 26,591 1.95 51,852
2025-03-03 Mara Joseph Anthony Jr (Chief Financial Officer) Sale 9,000 49.53 445,770
2025-03-03 Halpin Michael (Chief Operating Officer) Sale 10,000 49.52 495,200
2025-03-03 Halpin Michael (Chief Operating Officer) Option Ex 10,000 16.66 166,600
2025-03-03 Hopper Jonathan Mark (Chief Medical Officer) Sale 10,000 49.53 495,300
2025-03-03 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 10,000 18.00 180,000
2025-03-03 Hagen Heidi Sale 9,000 49.53 445,770
2025-03-03 Hagen Heidi Option Ex 9,000 3.74 33,660
2025-02-25 Siegal Jonathan (Principal Accounting Officer) Sale 1,137 52.07 59,203
2025-02-25 Flynn Sean C. (Chief Legal Officer) Sale 1,669 52.07 86,904
2025-02-24 Siegal Jonathan (Principal Accounting Officer) Option Ex 1,875 .00 0
2025-02-24 Mara Joseph Anthony Jr (Chief Financial Officer) Option Ex 4,625 .00 0
2025-02-24 Flynn Sean C. (Chief Legal Officer) Option Ex 3,000 .00 0
2025-02-24 Halpin Michael (Chief Operating Officer) Option Ex 5,250 .00 0
2025-02-24 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 3,000 .00 0
2025-02-24 Colangelo Dominick (President and CEO) Option Ex 18,250 .00 0
2025-02-20 Flynn Sean C. (Chief Legal Officer) Sale 3,835 57.32 219,822
2025-02-05 Siegal Jonathan (Principal Accounting Officer) Sale 1,092 61.99 67,693
2025-02-05 Siegal Jonathan (Principal Accounting Officer) Option Ex 1,092 48.80 53,289
2025-02-05 Zerbe Robert L Md Sale 2,500 62.50 156,250
2025-02-05 Zerbe Robert L Md Option Ex 2,500 13.05 32,625
2025-01-28 Siegal Jonathan (Principal Accounting Officer) Sale 3,908 61.99 242,256
2025-01-28 Siegal Jonathan (Principal Accounting Officer) Option Ex 3,908 48.80 190,710
2024-12-04 Wotton Paul K Sale 2,600 58.72 152,672
2024-12-02 Hopper Jonathan Mark (Chief Medical Officer) Sale 10,000 58.72 587,200
2024-12-02 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 10,000 16.66 166,600
2024-11-14 Colangelo Dominick (President and CEO) Sale 17,500 53.93 943,775
2024-11-14 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-11-13 Colangelo Dominick (President and CEO) Sale 17,500 55.57 972,475
2024-11-13 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-11-13 Mclaughlin Kevin F Sale 7,000 55.54 388,780
2024-11-13 Mclaughlin Kevin F Option Ex 7,000 3.74 26,180
2024-10-17 Hagen Heidi Option Ex 10,000 3.74 37,400
2024-10-17 Colangelo Dominick (President and CEO) Sale 17,500 40.34 705,950
2024-10-17 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-10-16 Gilman Steven C Sale 5,833 41.36 241,252
2024-10-16 Gilman Steven C Option Ex 5,833 13.05 76,120
2024-10-16 Colangelo Dominick (President and CEO) Sale 17,500 41.38 724,150
2024-10-16 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-10-02 Gilman Steven C Sale 5,833 40.35 235,361
2024-10-02 Gilman Steven C Option Ex 5,833 13.05 76,120
2024-10-01 Siegal Jonathan (Principal Accounting Officer) Sale 568 41.90 23,799
2024-09-30 Siegal Jonathan (Principal Accounting Officer) Option Ex 937 .00 0
2024-09-18 Gilman Steven C Sale 5,834 45.54 265,680
2024-09-18 Gilman Steven C Option Ex 5,834 13.05 76,133
2024-09-12 Colangelo Dominick (President and CEO) Sale 17,500 43.90 768,250
2024-09-12 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-09-11 Colangelo Dominick (President and CEO) Sale 17,500 43.37 758,975
2024-09-11 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-09-04 Gilman Steven C Sale 5,000 48.58 242,900
2024-09-04 Gilman Steven C Option Ex 5,000 3.74 18,700
2024-09-03 Hopper Jonathan Mark (Chief Medical Officer) Sale 10,000 49.83 498,300
2024-09-03 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 10,000 10.95 109,500
2024-08-15 Colangelo Dominick (President and CEO) Sale 17,500 46.24 809,200
2024-08-15 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-08-14 Colangelo Dominick (President and CEO) Sale 17,500 45.17 790,475
2024-08-14 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-08-07 Mclaughlin Kevin F Sale 7,000 45.95 321,685
2024-08-07 Mclaughlin Kevin F Option Ex 7,000 3.74 26,180
2024-07-18 Colangelo Dominick (President and CEO) Sale 17,500 51.40 899,500
2024-07-18 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-07-17 Colangelo Dominick (President and CEO) Sale 17,500 51.55 902,125
2024-07-17 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-07-16 Flynn Sean C. (Chief Legal Officer) Sale 15,000 52.18 782,700
2024-07-16 Flynn Sean C. (Chief Legal Officer) Option Ex 15,000 16.25 243,750
2024-07-12 Mara Joseph Anthony Jr (Chief Financial Officer) Sale 5,000 50.00 250,000
2024-07-05 Siegal Jonathan (Principal Accounting Officer) Sale 545 45.00 24,525
2024-06-24 Flynn Sean C. (Chief Legal Officer) Sale 1,474 45.84 67,568
2024-06-24 Flynn Sean C. (Chief Legal Officer) Option Ex 1,474 16.25 23,952
2024-06-21 Flynn Sean C. (Chief Legal Officer) Sale 6,772 45.02 304,875
2024-06-21 Flynn Sean C. (Chief Legal Officer) Option Ex 6,772 16.25 110,045
2024-06-20 Flynn Sean C. (Chief Legal Officer) Sale 6,754 45.04 304,200
2024-06-20 Flynn Sean C. (Chief Legal Officer) Option Ex 6,754 16.25 109,752
2024-06-13 Colangelo Dominick (President and CEO) Sale 17,500 43.10 754,250
2024-06-13 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-06-12 Colangelo Dominick (President and CEO) Sale 17,500 44.12 772,100
2024-06-12 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-05-20 Hopper Jonathan Mark (Chief Medical Officer) Sale 10,000 49.99 499,900
2024-05-20 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 10,000 10.95 109,500
2024-05-01 Wright Lisa Option Ex 3,200 .00 0
2024-05-01 Hagen Heidi Option Ex 3,200 .00 0
2024-05-01 Gilman Steven C Option Ex 3,200 .00 0
2024-05-01 Rubino Alan L Option Ex 3,200 .00 0
2024-05-01 Wotton Paul K Option Ex 3,200 .00 0
2024-05-01 Zerbe Robert L Md Option Ex 3,200 .00 0
2024-05-01 Mclaughlin Kevin F Option Ex 3,200 .00 0
2024-04-30 Colangelo Dominick (President and CEO) Option Ex 25,445 13.95 355,034
2024-04-18 Colangelo Dominick (President and CEO) Sale 35,000 44.59 1,560,650
2024-04-18 Colangelo Dominick (President and CEO) Option Ex 35,000 3.02 105,700
2024-04-17 Colangelo Dominick (President and CEO) Sale 35,000 46.47 1,626,450
2024-04-17 Colangelo Dominick (President and CEO) Option Ex 35,000 3.02 105,700
2024-03-27 Zerbe Robert L Md Sale 3,278 51.57 169,046
2024-03-27 Zerbe Robert L Md Option Ex 3,278 3.74 12,259
2024-03-08 Flynn Sean C. (SVP, General Counsel) Sale 8,115 45.33 367,852
2024-03-07 Siegal Jonathan (Principal Accounting Officer) Sale 1,634 45.00 73,530
2024-02-20 Siegal Jonathan (Principal Accounting Officer) Option Ex 2,920 .00 0
2024-02-20 Mara Joseph Anthony Jr (Chief Financial Officer) Option Ex 7,380 .00 0
2024-02-20 Flynn Sean C. (SVP, General Counsel) Option Ex 7,075 .00 0
2024-02-20 Halpin Michael (Chief Operating Officer) Option Ex 11,887 .00 0
2024-02-20 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 7,075 .00 0
2024-02-20 Colangelo Dominick (President and CEO) Option Ex 38,887 .00 0
2024-02-20 Zerbe Robert L Md Sale 722 50.01 36,107
2024-02-20 Zerbe Robert L Md Option Ex 722 3.74 2,700
2024-02-15 Colangelo Dominick (President and CEO) Sale 17,500 48.85 854,875
2024-02-15 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-02-14 Colangelo Dominick (President and CEO) Sale 17,500 46.99 822,325
2024-02-14 Colangelo Dominick (President and CEO) Option Ex 17,500 3.02 52,850
2024-02-12 Halpin Michael (Chief Operating Officer) Option Ex 3,500 .00 0
2024-02-12 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 1,625 .00 0
2024-02-12 Colangelo Dominick (President and CEO) Option Ex 7,500 .00 0
2024-01-29 Zerbe Robert L Md Sale 2,300 44.22 101,706
2024-01-22 Zerbe Robert L Md Sale 8,000 41.83 334,664
2024-01-22 Zerbe Robert L Md Option Ex 3,000 4.12 12,360
2024-01-12 Zerbe Robert L Md Sale 2,200 38.09 83,798
2023-12-14 Flynn Sean C. (SVP, General Counsel) Sale 106 37.45 3,969
2023-12-14 Colangelo Dominick (President and CEO) Sale 12,000 37.12 445,439
2023-12-14 Colangelo Dominick (President and CEO) Option Ex 12,000 3.57 42,840
2023-12-14 Wotton Paul K Sale 5,000 37.31 186,550
2023-12-13 Flynn Sean C. (SVP, General Counsel) Sale 1,432 34.20 48,974
2023-12-13 Colangelo Dominick (President and CEO) Sale 12,000 34.03 408,360
2023-12-13 Colangelo Dominick (President and CEO) Option Ex 12,000 3.57 42,840
2023-12-07 Colangelo Dominick (President and CEO) Sale 12,000 33.84 406,080
2023-12-07 Colangelo Dominick (President and CEO) Option Ex 12,000 3.57 42,840
2023-12-06 Colangelo Dominick (President and CEO) Sale 12,397 34.43 426,828
2023-12-06 Colangelo Dominick (President and CEO) Option Ex 12,397 3.57 44,257
2023-11-30 Halpin Michael (Chief Operating Officer) Sale 17,447 35.41 617,798
2023-11-30 Halpin Michael (Chief Operating Officer) Option Ex 17,447 7.20 125,618
2023-11-20 Hopper Jonathan Mark (Chief Medical Officer) Sale 5,000 36.40 182,000
2023-11-20 Hopper Jonathan Mark (Chief Medical Officer) Option Ex 5,000 10.95 54,750
2023-10-02 Siegal Jonathan (Principal Accounting Officer) Option Ex 938 .00 0
2023-07-14 Zerbe Robert L Md Sale 1,000 38.84 38,840
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of VCEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vericel Corp (symbol VCEL, CIK number 887359) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.